Back to Search
DINO VALLERA, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1821099599Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
Research & Publications (20)
Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.
PMID 19517064·J Neurooncol·2009
7-preclinical
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy.
PMID 19327829·Leuk Res·2009
7-preclinical
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.
PMID 18222985·Gut·2008
7-preclinical
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model.
PMID 18084721·J Neurooncol·2008
7-preclinical
A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth factor receptors in a mouse xenograft model of prostate cancer.
PMID 17975161·Clin Cancer Res·2007
7-preclinical
Radiotherapy of CD45-expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibody.
PMID 17803443·Cancer Biother Radiopharm·2007
7-preclinical
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv.
PMID 17505009·Clin Cancer Res·2007
7-preclinical
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice.
PMID 17075792·Int J Cancer·2007
7-preclinical
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice.
PMID 16358262·Int J Cancer·2006
7-preclinical
Independent quantitative trait loci influence ventral and dorsal hippocampal volume in recombinant inbred strains of mice.
PMID 17081266·Genes Brain Behav·2006
4-observational
Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
PMID 16709029·Neurosurg Focus·2006
7-preclinical
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.
PMID 16314943·J Neurooncol·2006
4-observational
Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
PMID 15778881·Psychopharmacology (Berl)·2005
4-observational
Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody.
PMID 16278417·Clin Cancer Res·2005
7-preclinical
A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
PMID 15897589·Clin Cancer Res·2005
7-preclinical
Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.
PMID 15661270·Leuk Res·2005
7-preclinical
Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.
PMID 15068607·Cancer Biother Radiopharm·2004
7-preclinical
A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
PMID 15047912·Protein Eng Des Sel·2004
7-preclinical
The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
PMID 12479856·Leuk Res·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 120 N OAK ST, HINSDALE HOSPITAL / PATHOLOGY DEP
HINSDALE, IL 60521 - Phone
- (630) 856-7850
Quick Facts
- NPI
- 1821099599
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile